Osteonecrosis of The Jaw: Dental Outcomes in Metastatic Breast Cancer Patients Treated With Bisphosphonates With/Without Bevacizumab

American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update

Salvatore L. Ruggiero, Thomas B. Dodson, Leon A. Assael et al. · Journal of Oral and Maxillofacial Surgery · 2009 · 1.3K citations

Dentistry, Maxillofacial Surgery, Oral Surgery +8

Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

Aristotle Bamias, Efstathios Kastritis, Christina Bamia et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

Medicine, Oncology, Bone Metabolism +9

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors

Ashraf Badros, Dianna Weikel, Andrew Salama et al. · Journal of Clinical Oncology · 2006 · 596 citations

Dentistry, Oral Pathology, Oral Radiology +12

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

Pierrick G.J. Fournier, Stéphanie Filleur, Julien Guglielmi et al. · PubMed · 2002 · 571 citations

Medicine, Endocrinology, Pharmacology +15

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

Eric Van Cutsem, Fernando Rivera, Scott Berry et al. · Annals of Oncology · 2009 · 534 citations

Medicine, Oncology, Pharmacotherapy +10